⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 1, 1989The Journal of Infectious Diseases

The Case for Patient Access to Experimental Therapy

View at Publisher

Ask AI

Bookmark

Share

Abstract

Martin Delaney; The Case for Patient Access to Experimental Therapy, The Journal of Infectious Diseases, Volume 159, Issue 3, 1 March 1989, Pages 416–419, https

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

M. L. Delaney (1989) studied this question.

synapsesocial.com/papers/6a7dd41087be3f923b5ca6b5 https://doi.org/10.1093/infdis/159.3.416

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1EBV-infected cell lineage by EBER double-staining as a diagnostic and prognostic clue in pediatric EBV-related lymphoproliferative disorders: a Japanese central pathology cohort studyThe Journal of Infectious Diseases · Fri,
2Impact of Dose on Norovirus Antibody Kinetics Following Infection or VaccinationThe Journal of Infectious Diseases · Fri,
3Host Immune Biosignatures Predict Septic Shock and Mortality in Solid Organ Transplant Recipients With Gram-Negative BacteremiaThe Journal of Infectious Diseases · Mon,
4The host transcriptional response to real-world cryptococcosis in the setting of advanced HIV disease defines dysregulated immune responses that underlie increased vulnerability to infectionThe Journal of Infectious Diseases · Wed,
5Population-level shift in ex vivo artemisinin susceptibility in Plasmodium falciparum : comparison of 2014–2015 and 2022–2024 surveys in northern UgandaThe Journal of Infectious Diseases · Tue,

More from The Journal of Infectious Diseases

Carbapenemase-producing Kluyvera spp.: epidemiology of an evolving speciesMon,
Changes in Doravirine Pharmacokinetics During Pregnancy: A Longitudinal Single Dose StudyFri,
Risk maps and spatial models for clinical infectious disease decision-makingFri,
The Power of Storytelling in Science: Perspectives from Two Students and a Community MemberTue,
Rationale for a live-attenuated vaccine for cryptosporidiosisTue,